456
456
592
592
643
643
645
645
722
722
703
703
516
516
464
464
361
361
306
306
2019
2010
Company (11.1K)University (360)Hospital (45)Research Institution (43)Investor (2)Foundation (1)
1 - 10 of 11,174
Sort by
Patent
Publication NumberUS 20200096500Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-01-08Publication Date2020-03-26
This invention provides a method for measuring glucose metabolism ability of a subject and a composition that is suitably used in the method. The method for measuring glucose metabolism ability of the present invention is as follows: a method for measuring glucose metabolism ability of a subject, using a composition for measuring glucose metabolism ability, the composition comprising, as an active ingredient, glucose labeled with at least one isotope of C, wherein the glucose is converted in …
Patent
Publication NumberUS 20200093700Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-05-01Publication Date2020-03-26
Provided is packaged medicine capable of inhibiting deterioration of electrodes over a long period of time and reliably transmitting a signal after ingestion even when a long period of time has elapsed since production to ingestion. The packaged medicine includes a solid medicine including drug powder and a micro-device, a container provided with a solid medicine accommodating space accommodating the solid medicine therein, and inert gas encapsulated in the solid medicine accommodating space.…
Patent
Publication NumberUS 20200093823Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-11-26Publication Date2020-03-26
The present invention relates to a method of treating a patient suffering from a disorder of the central nervous system associated with 5-HT1A receptor subtype, comprising as an active ingredient a carbostyril derivative or a salt thereof represented by the formula (1) wherein the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or a double bond.
Patent
Publication NumberUS 20200093748Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-09-27Publication Date2020-03-26
The invention provides a method of preparing a lyophilized pharmaceutical composition containing a compound described herein or a pharmaceutically-acceptable salt thereof. The process comprises dissolving the compound in a solvent comprising dimethylsulfoxide and optionally one or more co-solvents to form a solution, and then removing the solvent and any co-solvents by a freeze-drying process. Also provided by the invention are lyophilized pharmaceutical compositions and their use in medicine…
Patent
Publication NumberUS 20200095191Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-04-27Publication Date2020-03-26
The present invention relates to a 5-step process for preparing iosimenol starting from ammonium 3-amino-5-(aminocarbonyl)benzoate which is first converted to 3-amino-5-(aminocarbonyl)-2,4,6-triiodobenzoic acid using sodium iodine dichloride (NaI—Cl2). The present invention further relates to processes for purifying iosimenol.
Patent
Publication NumberUS 20200085848Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-09-18Publication Date2020-03-19
This invention relates to methods and compositions for administering an effective amount of a CDA substrate drug and an effective amount of cedazuridine. In particular, the invention relates to methods for treating cancer, inhibiting degradation of a CDA substrate drug, and reducing DNA methylation in a subject in need thereof comprising administering an effective amount of a CDA substrate drug and an effective amount of cedazuridine.
Patent
Publication NumberUS 10588893Filing StatusIssued PatentAvailabilityUnknownFiling Date2016-12-27Publication Date2020-03-17
An ointment is provided. The ointment stably comprises an oxazole compound that has specific inhibitory activity against PDE4 and that is represented by the following formula (11). The ointment can be efficiently absorbed into the skin.
Patent
Publication NumberUS 20200078340Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-11-12Publication Date2020-03-12
The present invention provides a oxazole compound represented by Formula (1), or a salt thereof: wherein R1 is an aryl group which may have one or more substituents; R2 is an aryl group or a nitrogen atom-containing heterocyclic group each of which may have one or more substituents; and W is a divalent group represented by —Y1-A1- or —Y2—C(═O)— wherein Y1 is a group such as —C(═O)—, A1 is a group such as a lower alkylene group, and Y2 is a group such as a piperazinediyl group. The oxazole com…
Patent
Publication NumberUS 20200061056Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-10-29Publication Date2020-02-27
Provided is a superior, novel heterocyclic compound with improved solubility in oil such as sesame oil and benzyl benzoate, which has a broader treatment spectrum, causes less side effects, and is superior in tolerability and safety, and use thereof. A heterocyclic compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.
Patent
Publication NumberUS 20200055823Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2019-10-22Publication Date2020-02-20
The present invention provides a compound represented by the formula (I) wherein X is a hydrogen atom or a fluorine atom; R is a hydrogen atom or alkyl; R1 is (1) cyclopropyl optionally substituted by 1 to 3 halogen atoms or (2) phenyl optionally substituted by 1 to 3 halogen atoms; R2 is alkyl, alkoxy, haloalkoxy, a halogen atom, cyano, etc.; and R3 is 7-oxo-7,8-dihydro-1,8-naphthyridinyl, 3-pyridyl, etc., or a salt thereof. The compound of the present invention has excellent antimicrobial a…
We found 11,174 documents that match your Search
Research Grants: 2
Patents: 10,777
Clinical Trials: 395

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in